Astellas Pharma Inc. Stock Deutsche Boerse AG
Stocks
YPH
JP3942400007
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
02:24:46 19/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 13.45 EUR | +2.67% |
|
+3.20% | +15.90% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,274B 27.23B 23.74B 22.42B 20.36B 38.14B 2,612B 38.3B 269B 104B 1,328B 102B 100B | P/E 2027 * |
11.3x | P/E 2028 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4,214B 26.85B 23.41B 22.11B 20.07B 37.61B 2,576B 37.77B 265B 102B 1,310B 101B 98.62B | EV / Sales 2027 * |
1.8x | EV / Sales 2028 * | 1.74x |
| Free-Float |
98.92% | Yield 2027 * |
3.36% | Yield 2028 * | 3.49% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4503 | Delayed | |
Mexican S.E.
| 4503 N | End-of-day quote | |
|
OTC Markets
| ALPMF | Delayed | |
|
Tradegate
| YPH | Real-time | |
|
Boerse Muenchen
| YPH | Real-time | |
|
Deutsche Boerse AG
| YPH | Delayed | |
|
Börse Stuttgart
| YPH | Delayed |
Last Transcript: Astellas Pharma Inc.
| 1 day | +2.67% | ||
| 1 week | +3.20% | ||
| Current month | +4.03% | ||
| 1 month | +5.74% | ||
| 3 months | +10.26% | ||
| 6 months | +0.62% | ||
| Current year | +15.90% |
| 1 week | 12.5 |  | 13.1 |
| 1 month | 11.9 | | 13.3 |
| Current year | 11 | | 14.19 |
| 1 year | 8.56 | | 14.19 |
| 3 years | 7.53 | | 14.19 |
| 5 years | 7.53 | | 16 |
| 10 years | 7.53 | | 16.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 64 | 01/06/2019 |
| Director/Board Member | 59 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.67% | +3.20% | - | - | 27.22B | |
| -0.19% | +2.84% | +50.39% | +100.84% | 1,027B | |
| +0.45% | +2.03% | +55.59% | +66.78% | 651B | |
| +0.46% | +2.96% | +19.25% | +71.97% | 467B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 350B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 268B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 257B | |
| +1.33% | +1.68% | +39.10% | +45.80% | 205B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 190B | |
| +0.37% | +5.06% | +32.89% | +99.67% | 187B | |
| Average | +0.39% | +2.49% | +26.17% | +45.36% | 400.23B | |
| Weighted average by Cap. | +0.06% | +2.62% | +35.11% | +61.72% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,338B 14.89B 12.99B 12.26B 11.14B 20.86B 1,429B 20.95B 147B 56.69B 727B 55.95B 54.71B | 2,180B 13.89B 12.11B 11.43B 10.38B 19.45B 1,333B 19.54B 137B 52.86B 678B 52.17B 51.01B |
| Net income | 361B 2.3B 2.01B 1.89B 1.72B 3.22B 221B 3.24B 22.69B 8.75B 112B 8.64B 8.45B | 340B 2.16B 1.89B 1.78B 1.62B 3.03B 208B 3.04B 21.34B 8.24B 106B 8.13B 7.95B |
| Net Debt | -59.18B -377M -329M -310M -282M -528M -36.18B -530M -3.72B -1.43B -18.39B -1.42B -1.38B | -481B -3.06B -2.67B -2.52B -2.29B -4.29B -294B -4.31B -30.2B -11.65B -149B -11.5B -11.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | €12.90 | -1.53% | 0 |
| 17/09/26 | €13.10 | +3.97% | 0 |
| 16/09/26 | €12.60 | 0.00% | 0 |
| 15/09/26 | €12.60 | -0.79% | 0 |
| 14/09/26 | €12.70 | +1.60% | 100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- YPH Stock
Select your edition
All financial news and data tailored to specific country editions
